Biotech
Latest news, analysis, and insights about Biotech.
AI-designed viruses created by Arc Institute spark unprecedented medical breakthroughs and severe biosecurity risks.
Researchers at the Arc Institute have used generative AI to design completely novel viruses not found in nature. While this breakthrough could solve medicine's toughest delivery problems, it opens a biosecurity Pandora's box.
Why Google DeepMind's Bioresilience Strategy Will Shape the Future of Biotech Regulation
Google DeepMind and Isomorphic Labs have released a joint strategy for biological safety. This framework aims to mitigate the dual-use risks of advanced AI models in drug discovery and genetics.
Why Breakout Ventures Is Defying the Biotech Winter With a New $114M Early-Stage AI Fund
While traditional venture capital flees to clinical-stage safety, Breakout Ventures has closed a $114 million fund. Their bet? AI fundamentally breaks the cost curves of early-stage scientific discovery.
Why Lightspeed Is Backing Former OpenAI Researcher Miles Wang at a $2 Billion Valuation
OpenAI researcher Miles Wang is in talks to spin out a new AI drug discovery startup at a $2 billion valuation. The deal, reportedly led by Lightspeed, signals a massive shift toward verticalized AI in the physical sciences.
OpenAI-Backed Chai Discovery Hits $1.3B Valuation With Foundation Models for Drug Discovery
Chai Discovery just raised $130M at a $1.3 billion valuation, with OpenAI among its backers. The startup is applying foundation model techniques to predict molecular interactions—and it signals a broader AI-biotech convergence.